4\',7-Di-O-methylcatechin



Compound IDCDAMM02210
Common name4\',7-Di-O-methylcatechin
IUPAC name2-(3-hydroxy-4-methoxyphenyl)-7-methoxy-3,4-dihydro-2H-chromene-3,5-diol
Molecular formulaC17H18O6

Experimental data

Retention time9.72
Adduct[M+H]+
Actual mz319.118
Theoretical mz319.117
Error1.33
Ionizaton modePositive
Instrument typeLC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60
Score5.9205

Identifiers and class information

Inchi keyMWTVZZZJXLZCEN-UHFFFAOYNA-N
SmilesOC1=CC(=CC=C1OC)C2OC3=CC(OC)=CC(O)=C3CC2O
SuperclassPhenylpropanoids and polyketides
ClassFlavonoids

Pharmacokinetic properties

Number of descriptor values(#stars)0
Number of non-conjugated amine groups (#amine)0
Number of amidine and guanidine groups (#amidine)0
Number of carboxylic acid groups (#acid)0
Number of non-conjugated amide groups (#amide)0
Number of rotatable bonds (#rotor)5
Number of reactive functional groups (#rtvFG)0
Predicted central nervous system activity (CNS)-2
Molecular weight (mol_MW)318.326
Computed dipole moment(dipole)2.417
Total solvent accessible surface area (SASA)565.279
Hydrophobic component of SASA (FOSA)252.503
Hydrophilic component of SASA (FISA)136.536
Pie component of the SASA (PISA)176.24
Weakly polar component of the SASA (WPSA)0
Total solvent accesible volume (volume)982.679
Number of hydrogen bond donors (donorHB)3
Number of hydrogen bond acceptors (accptHB)5.45
Free energy of solvation of dipole (dip^2/V)0.0059443
Index of cohesive interaction in solids (ACxDN^.5/SA)0.0166991
Globularity descriptor (glob)0.845622
Predicted polarizability in cubic angstroms (QPpolrz)31.645
Predicted hexadecane/gas partition coefficient (QPlogPC16)10.21
Predicted octanol/gas partition coefficient (QPlogPoct)17.563
Predicted water/gas partition coefficient (QPlogPw)11.866
Predicted octanol/water partition coefficient (QPlogPo/w)2.154
Predicted aqueous solubility (QPlogS)-3.726
Conformation-independent predicted aqueous solubility (CIQPlogS)-4.179
Predicted IC50 value for blockage of HERG K+ channels (QPlogHERG)-4.87
Predicted apparent Caco-2 cell permeability in nm/sec (QPPCaco)502.493
Predicted brain/blood partition coefficient (QPlogBB)-1.011
Predicted apparent MDCK cell permeability in nm/sec (QPPMDCK)235.129
Predicted skin permeability, log Kp (QPlogKp)-2.935
PM3 calculated ionization potential (IP(ev))8.865
PM3 calculated electron affinity (EA(eV))0.017
Number of likely metabolic reactions (#metab)7
Prediction of binding to human serum albumin (QPlogKhsa)-0.03
Predicted qualitative human oral absorption (HumanOralAbsorption)3
Predicted human oral absorption on 0 to 100% scale (PercentHumanOralAbsorption)87.905
Solvent-accessible surface area of fluorine atoms (SAFluorine)0
Solvent-accessible surface area of amide oxygen atoms (SAamideO)0
Van der Waals surface area (PSA)87.276
Number of nitrogen and oxygen atoms (#NandO)6
Number of violations of Lipinski’s rule of five (RuleOfFive)0
Number of violations of Jorgensen’s rule of three (RuleOfThree)1

Compound-target network

Cytoscape Graph

Protein targets associated with phytocompound

Uniprot ID Gene name Target name TTD_ID Prediction source
P43166CA7Carbonic anhydrase VIIT37541SEA
P22748CA4Carbonic anhydrase IVT53378SEA
P11926ODC1Ornithine decarboxylaseT60366SEA
P11511CYP19A1Cytochrome P450 19A1T13260SEA
P33527ABCC1Multidrug resistance-associated protein 1T11288SEA
P08183ABCB1P-glycoprotein 1T25258SEA
P18054ALOX12Arachidonate 12-lipoxygenaseT35527SEA
P20151KLK2Kallikrein 2T01908SEA
P15692VEGFAVascular endothelial growth factor AT20761SEA
P49763PGFPlacenta growth factorT70792SEA
Q9UNQ0ABCG2ATP-binding cassette sub-family G member 2T56556SEA
P37023ACVRL1Serine/threonine-protein kinase receptor R3T36959SEA
P14679TYRTyrosinaseT97035SEA
P60842EIF4A1Eukaryotic initiation factor 4A-IT86805SEA
P52209PGD6-phosphogluconate dehydrogenaseT76497SEA
Q16678CYP1B1Cytochrome P450 1B1T92521SEA
P16152CBR1Carbonyl reductase [NADPH] 1T70518SEA
Q9H4B7TUBB1Tubulin beta-1 chainT84397SEA
Q9NZ70TAK1TGF-beta-activated kinase 1T04361SEA

Target associated diseases

TTD_ID Disease_ID Disease name ICD_11 Uniprot ID Gene names
T53378DI0046Bacterial infection[ICD-11: 1A00-1C4Z]P22748CA4
T53378DI0166Glaucoma[ICD-11: 9C61]P22748CA4
T53378DI0372Seborrhoeic dermatitis[ICD-11: EA81]P22748CA4
T60366DI0020African trypanosomiasis[ICD-11: 1F51]P11926ODC1
T13260DI0062Breast cancer[ICD-11: 2C60-2C6Y]P11511CYP19A1
T13260DI0108Cushing syndrome[ICD-11: 5A70]P11511CYP19A1
T11288DI0167Gout[ICD-11: FA25]P33527ABCC1
T25258DI0238Lung cancer[ICD-11: 2C25]P08183ABCB1
T01908DI0213Innate/adaptive immunodeficiency[ICD-11: 4A00]P20151KLK2
T20761DI0095Colorectal cancer[ICD-11: 2B91]P15692VEGFA
T20761DI0365Retinopathy[ICD-11: 9B71]P15692VEGFA
T20761DI0430Vascular system developmental anomaly[ICD-11: LA90]P15692VEGFA
T70792DI0095Colorectal cancer[ICD-11: 2B91]P49763PGF
T56556DI0218Irritable bowel syndrome[ICD-11: DD91]Q9UNQ0ABCG2
T56556DI0366Rheumatoid arthritis[ICD-11: FA20]Q9UNQ0ABCG2
T36959DI0391Solid tumour/cancer[ICD-11: 2A00-2F9Z]P37023ACVRL1
T97035DI0007Acquired hypermelanosis[ICD-11: ED60]P14679TYR
T97035DI0008Acquired hypomelanotic disorder[ICD-11: ED63]P14679TYR
T86805DI0391Solid tumour/cancer[ICD-11: 2A00-2F9Z]P60842EIF4A1
T76497DI0337Pituitary gland disorder[ICD-11: 5A60-5A61]P52209PGD
T70518DI0037Asthma[ICD-11: CA23]P16152CBR1
T84397DI0391Solid tumour/cancer[ICD-11: 2A00-2F9Z]Q9H4B7TUBB1
T04361DI0250Mature B-cell lymphoma[ICD-11: 2A85]Q9NZ70TAK1

Copyright © 2025